Talk:Robitussin

This is the talk page of a redirect that targets the page:
• Cold medicine
Because this page is not frequently watched, present and future discussions, edit requests and requested moves should take place at:
• Talk:Cold medicine

Pharmacology

This redirect is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles

Brands

This redirect is within the scope of WikiProject Brands, a collaborative effort to improve the coverage of brands on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.BrandsWikipedia:WikiProject BrandsTemplate:WikiProject BrandsBrands articles

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Robitussin.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Text and/or other creative content from this version of Robitussin DAC was copied or moved into Robitussin with this edit. The former page's history now serves to provide attribution for that content in the latter page, and it must not be deleted as long as the latter page exists.

Robitussin AC and OTC status in the US

Actually, AC and I think DAC can be sold over the counter legally in the same way pseudoephedrine is, but since AC/DAC is a schedule V drug, it's up to the individual pharmacy on whether or not to make the sale. Many opt to not sell it OTC because it contains codeine. — Preceding unsigned comment added by 71.162.63.43 (talk) 21:35, 26 April 2014 (UTC)[reply]

Ordinary Robitussin/merger

Why was the article "Robitussin" merged into this article? Robitussin DAC was a completely unknown concept to me until I saw this Wikipedia article. To me (in the USA), "Robitussin" refers to an over-the-counter product that contains no narcotics. I think that the article should give greater prominence to the other varieties (which aren't really mentioned at all) and say that the DAC version is less common in the USA (assuming that it is indeed). Ardric47 (talk) 01:23, 15 May 2014 (UTC)[reply]

I agree. At least in the US, the most common form of Robitussin contains dextromethorphan. DAC is uncommon and hard to get unless you have a prescription. Robitussin offers a variety of different products so we should change the article to include information on their medicines besides the codeine/guaifenesin preparation. —Reelcheeper (talk) 01:05, 5 June 2014 (UTC)[reply]

Requested move 31 August 2015

The following is a closed discussion of a requested move. Please do not modify it. Subsequent comments should be made in a new section on the talk page. Editors desiring to contest the closing decision should consider a move review. No further edits should be made to this section.

The result of the move request was: moved. History swap performed to preserve the article history for attribution. Jenks24 (talk) 06:56, 8 September 2015 (UTC)[reply]

Robitussin DAC → Robitussin – An article with the title "Robitussin" was merged into "Robitussin DAC" years ago. Now, the single article has been reworked to include information about the ingredients of many different OTC products sold under the Robitussin name, along with the original information on Robitussin DAC/AC. More info on specific Robitussin products, especially those from countries besides the U.S., is still needed. But since the article now covers a wider base, it should be moved to Robitussin. Reelcheeper (talk) 09:19, 31 August 2015 (UTC)[reply]

Support per nom. FoCuS contribs; talk to me! 19:39, 31 August 2015 (UTC)[reply]

The above discussion is preserved as an archive of a requested move. Please do not modify it. Subsequent comments should be made in a new section on this talk page or in a move review. No further edits should be made to this section.